Practo

Practo Competitive Intelligence & Landscape

practo.com ·

Practo
ForesightIQ Predictions

What is Practo likely to do next?

ForesightIQ connects Practo's hiring, product, web, ad, and market signals to forecast strategic moves — often months before they're announced.

Hiring signal

Senior hiring patterns point to a planned enterprise product line launching within two quarters.

High confidence · Next 1–2 quarters
Product signal

Quiet changes to docs and pricing pages signal an upcoming usage-based pricing tier and new API surface.

Likely · Next quarter
Market signal

Ad spend and partnership activity indicate a push into the mid-market segment across two new regions.

Plausible · Next 2–3 quarters
Practo Unlock Practo's predicted moves

Free · generated in ~60 seconds · no signup to preview

Overview

Practo Overview

Practo is a leading healthcare technology company founded in 2008 and headquartered in Bangalore, India. It aims to improve health outcomes by connecting patients, healthcare providers, pharmacies, diagnostics, clinics, and hospitals through its integrated platform, making healthcare more accessible, affordable, and convenient (Exa). The company's core offerings include practice management software, telemedicine services, online consultation platforms, and digital health records, facilitating seamless interactions within the healthcare ecosystem (Exa).

Practo's target market spans over 22 countries, with a significant presence in India and recent expansion into the UAE, serving over 50 crore patients and connecting more than 5 lakh healthcare providers across 900 cities (Exa). Its services cater to both consumers seeking healthcare access and healthcare providers looking to digitize and optimize their practices. The company's mission is to simplify healthcare and empower individuals to make informed health decisions, leveraging data science and secure technology standards like HIPAA compliance and ISO 27001 certification (Exa).

With a workforce of approximately 858 employees and annual revenues around USD 24.6 million, Practo continues to grow rapidly, recently reporting a 90% improvement in EBITDA for FY24 and ongoing efforts to raise funds for future expansion, including a pre-IPO round (Exa). Its competitive edge lies in its comprehensive platform, security standards, and global reach, making it a prominent player in the health tech industry.

Competitors

Practo Competitors

Klaim is a notable competitor to Practo, offering working capital solutions across sectors including healthcare, and emphasizing its financial services for healthcare providers. Its market positioning is distinct due to its focus on financial solutions rather than direct healthcare management, making it a unique player in the healthcare ecosystem (CB Insights).

Helium Health specializes in digital health tools and financing solutions for healthcare providers, primarily operating in Africa. Its key differentiator is its focus on digital health infrastructure and financing, positioning itself as a comprehensive health-tech platform that supports healthcare delivery and management (CB Insights). Compared to Practo, Helium Health emphasizes health system strengthening through technology and financing, rather than patient-facing services.

Zocdoc (mentioned in a related sector) is a prominent US-based platform that enables patients to book medical appointments online. Its market position is strengthened by its extensive network of healthcare providers and user-friendly interface, focusing on appointment management and telehealth services. Unlike Practo, Zocdoc primarily operates in the US and emphasizes appointment scheduling and patient reviews, with a competitive edge in user experience and provider network size (CB Insights).

Lybrate is an Indian digital health platform that connects patients with doctors for online consultations, health advice, and medicine delivery. It differentiates itself through its comprehensive health services, including health tips, online consultations, and a large network of doctors, making it a direct competitor in the Indian market. Compared to Practo, Lybrate emphasizes accessible telemedicine and health information, targeting a broad consumer base with a focus on affordability and ease of access (Ahrefs).

Yodawy (another competitor in the broader healthcare tech space) offers pharmacy and medicine delivery services, integrating with healthcare providers for medication management. Its market niche is in pharmacy logistics and medication adherence, complementing Practo’s broader healthcare management services but focusing more on supply chain and medication delivery solutions (CB Insights).

Alternatives

Practo Alternatives

Product & Pricing

Practo Product and Pricing Intelligence

Practo offers a range of products with varying features and pricing plans tailored to different user needs. The Practo Tab subscription, for example, can be purchased along with Ray Atom or CM plans, with an additional hardware cost of INR 17,000 (one-time) and a monthly subscription fee of INR 750 (Practo Help). This subscription is linked to a specific tablet device and can be canceled with a refund policy in place.

For telemedicine, Practo Prime provides high-quality doctor visits with no additional charge for patients, although consultation fees are paid to the doctors (Practo Help). The platform fee for Practo Prime Online was revised from 20% to 30% per connection in August 2022, reflecting industry growth and the need for enhanced platform services (Practo Help).

Additionally, Practo’s Ray Connect virtual assistant service offers plans starting at Rs. 999 per month for 1000 credits, with discounts available for longer-term commitments, aimed at improving clinic call management (Practo Help). Overall, Practo’s pricing structure combines subscription-based models, pay-per-use services, and tiered plans to cater to healthcare providers and patients, with recent updates emphasizing increased platform fees and expanded telehealth capabilities.

Hiring & Layoffs

Practo Hiring and Layoffs

Recent developments indicate that Practo is actively expanding its global footprint, especially into developed markets like the US, aiming to double its international revenue over the next three years (Reuters). This strategic focus on international growth suggests a company prioritizing market diversification and scaling operations.

In terms of hiring trends, there is limited specific data on recent new job openings, but the company's push into new markets and increased transaction volumes in categories like dental and mental health imply ongoing hiring to support expansion and product development (YourStory). Notably, in April 2023, Practo laid off 41 employees, mostly engineers, which indicates a possible restructuring phase to optimize costs or realign resources with strategic priorities (The Economic Times).

Overall, Practo's hiring patterns and recent layoffs suggest a company in a strategic transition—focusing on international market expansion and operational efficiency. This signals a shift toward consolidating its core strengths while exploring new growth avenues, which could lead to increased hiring in areas aligned with its international expansion and healthcare technology innovations.

Leadership

Practo Management and Leadership Team

As of March 2026, Practo is led by its founder and CEO Shashank ND, who has been instrumental in shaping the company's vision to improve healthcare access through digital platforms (Tracxn). Shashank has over 17 years of experience in healthcare and technology, and he also serves as the Chairman of the CII Subcommittee on Digital Health, emphasizing his leadership in digital health initiatives (Result 1).

Recent leadership developments include the appointment of Cijo George as Vice President of AI in March 2026, tasked with advancing Practo’s AI strategy across care navigation and platform intelligence, reflecting the company's focus on AI-driven healthcare solutions (Result 5). Additionally, Shoumyan Biswas was appointed as the Global Chief Strategy and Marketing Officer in 2025, leading global expansion and customer engagement strategies (Result 6).

While specific details about the board members are limited, these recent executive hires and leadership changes highlight Practo’s strategic focus on AI, international growth, and digital health innovation.

Financials

Practo Financial Performance, Fundraising, M&A

Practo has demonstrated significant financial progress in recent years, achieving profitability in FY25, which marked its first full year of sustained profit over six consecutive quarters. The company reported a revenue of ₹234 crore (approximately $28 million) in FY25, along with a gross merchandise value (GMV) exceeding ₹3,500 crore (about $420 million), and an operating EBITDA of ₹15 crore (about $1.8 million) (Practo Blog). This turnaround from a loss of ₹162 crore in FY22 highlights improved operational efficiency and growth in core segments (Practo Blog).

Regarding fundraising, Practo has accumulated total funding of approximately ₹1,665.59 crore (around $200 million), although specific recent rounds are not detailed in the available sources. The company has also been actively expanding internationally, aiming to double its revenue from international markets within three years, with about 20% of its revenue currently coming from these regions (Reuters).

As for mergers and acquisitions, there are no specific recent M&A activities reported in the sources. However, Practo continues to focus on expanding its healthcare services and digital health solutions, leveraging its extensive user base of over 40 crore consumers and 5 lakh healthcare providers, which positions it as a leading player in the digital health space (Practo Blog). Overall, Practo's financial health appears robust, with a clear trajectory toward profitability and growth in both domestic and international markets.

Partnerships

Practo Partnerships, Clients and Vendors

Practo has established a robust ecosystem through notable partnerships, enterprise clients, and strategic technology integrations. One of its significant milestones includes raising $55 million in Series D funding from Tencent and other investors in 2024, which aims to expand its integrated healthcare platform and international operations (Economic Times). Practo's ecosystem also includes collaborations with healthcare providers and clinics, leveraging its platform to connect users with a vast network of doctors and healthcare services across India, including telemedicine solutions and appointment booking (Google Play).

In terms of strategic acquisitions, Practo acquired Qikwell in 2015, a doctor appointment booking platform, to strengthen its service offerings and expand its reach within the healthcare ecosystem (YourStory). This acquisition helped Practo integrate more seamless appointment management and enhance its digital health services. Practo also maintains technology integrations with top clinics and hospitals, providing comprehensive telehealth and consultation services, which are accessible via its mobile app and online platform. These ecosystem relationships and partnerships position Practo as a key player in India's digital health landscape, with ongoing efforts to build an integrated health ecosystem (Tracxn).

Events

Practo Event Participations

Practo actively participates in various industry events, including conferences, trade shows, webinars, and community events, to promote its healthcare solutions and engage with the medical community. Notably, in 2019, Practo was honored by the Karnataka Ophthalmic Society for its significant contributions to digital healthcare at the iBeach Festival, highlighting its role in advancing Indian ophthalmology through innovative digital tools (BW Healthcare World). More recently, in September 2025, Practo hosted a webinar focused on India's obesity challenge, emphasizing gut health's crucial role, which aligns with its efforts to raise awareness on critical health issues (BW Healthcare World). While specific details about all the conferences, trade shows, or webinars Practo attends or hosts are not exhaustively listed, these examples demonstrate Practo's ongoing engagement in health-related events and community outreach initiatives.

Frequently Asked Questions

What does Practo's first sustained profitability in FY25 signal — genuine turnaround or a one-time inflection?

Practo's FY25 profitability looks like a structural turnaround rather than a one-time event: the company sustained positive EBITDA across six consecutive quarters, reaching operating EBITDA of ₹15 crore on ₹234 crore in revenue, compared to a ₹162 crore net loss in FY22. The GMV exceeding ₹3,500 crore suggests the underlying transaction engine is scaling, not just cost-cutting. That said, the EBITDA margin remains thin (~6%), so the turnaround is real but fragile — any aggressive international expansion spend could quickly reverse it.

What does the appointment of a VP of AI in March 2026 reveal about where Practo is placing its next product bets?

Bringing in Cijo George as Vice President of AI in March 2026, specifically tasked with care navigation and platform intelligence, signals that Practo is shifting from a directory/booking model toward an AI-driven clinical-decision and patient-routing layer. Combined with the earlier hire of Shoumyan Biswas as Global Chief Strategy and Marketing Officer to lead international expansion, the leadership build-out suggests Practo is betting that AI differentiation will be the wedge for both domestic upsell and international market entry, particularly in the US.

What does Practo's goal to double international revenue in three years imply about where it expects domestic growth to plateau?

Practo's explicit target to double international revenue over three years — with international currently representing roughly 20% of total revenue — implies management believes the Indian market alone cannot sustain the growth rate needed to justify a pre-IPO valuation. The early traction in the US market and the UAE presence suggest a two-geography international thesis rather than a broad multi-market scatter. For corp-dev analysts, this is a signal that Practo may be receptive to distribution partnerships or acquisitions in the US and Gulf markets to accelerate that timeline.

What did the April 2023 engineer layoffs of 41 employees tell us about Practo's cost structure priorities ahead of its profitability push?

The April 2023 layoffs — concentrated in engineering — indicate Practo was deliberately trimming R&D headcount to compress its cost base as it pushed toward EBITDA breakeven, which it achieved by FY25. This is consistent with a company consolidating its product surface area rather than building new features broadly. The fact that it then hired a VP of AI in 2026 suggests the restructuring phase is over and selective, high-value technical hiring has resumed, now oriented around AI rather than general engineering capacity.

Is Practo's platform fee increase from 20% to 30% per telemedicine connection a margin lever or a competitive risk?

The August 2022 revision of Practo Prime Online's platform fee from 20% to 30% is a meaningful margin lever — a 50% increase in take rate on every consultation — but it carries competitive risk in a market where Lybrate and other Indian telemedicine players compete on affordability. The move is consistent with Practo's path to EBITDA profitability achieved in FY25, suggesting the fee hike held without significant doctor or patient attrition. However, as Practo pushes into the US, where Zocdoc and others operate with different fee structures, pricing strategy will need to be reassessed market by market.

What does Practo's competitive set — Lybrate domestically and Zocdoc in the US — reveal about the strategic gaps it must close to win internationally?

Domestically, Lybrate competes with Practo on telemedicine and health information for price-sensitive consumers, meaning Practo's moat at home rests on its broader platform (practice management, diagnostics, pharmacy) rather than any single feature. In the US, Zocdoc's competitive edge is its provider network depth and user experience in appointment scheduling — an area where Practo is an early entrant without an established brand. Closing that gap in the US likely requires either a provider-network acquisition or a partnership-led go-to-market, rather than organic build, given the three-year revenue-doubling target.

What does Shashank ND's role as CII Subcommittee Chair on Digital Health signal about Practo's regulatory and policy positioning?

Shashank ND's chairmanship of the CII Subcommittee on Digital Health positions Practo as an active shaper of India's digital health policy environment, not merely a compliant participant. This is strategically valuable as India's National Digital Health Mission evolves — Practo gains early visibility into regulatory frameworks and can influence interoperability standards that would benefit its existing HIPAA- and ISO 27001-compliant infrastructure. For competitors, it means Practo has a structural early-warning advantage on policy shifts that could affect telemedicine pricing, data-sharing mandates, or licensing requirements.

What does Practo's Tencent-backed Series D and the absence of reported recent funding rounds suggest about its current capital strategy?

Practo's last clearly documented external funding was a $55 million Series D involving Tencent, and the company has accumulated approximately $200 million in total funding. The current narrative centers on a pre-IPO round rather than another venture round, which — combined with six consecutive quarters of positive EBITDA — suggests Practo is positioning for a public markets exit rather than further dilutive private financing. The absence of reported M&A activity in recent years further supports a capital-preservation posture ahead of a listing, though the international expansion ambition could trigger acquisitions if organic traction in the US proves slow.

What does Practo's webinar on India's obesity and gut health challenge in September 2025 signal about its content and category strategy?

Hosting a webinar on India's obesity and gut health challenge aligns with Practo's reported growth in non-traditional consultation categories — dental and mental health are cited as high-growth transaction segments. Obesity and metabolic health represent a large, underpenetrated chronic-care opportunity in India, and owning the awareness and education layer through webinars is a low-cost top-of-funnel strategy to drive consultations on the platform. This suggests Practo is deliberately expanding its clinical category footprint beyond acute-care bookings toward higher-frequency, higher-lifetime-value chronic condition management.

What does Practo's scale — 500,000 providers across 900 cities and 40+ crore consumers — mean for its defensibility against new entrants?

A network of 5 lakh healthcare providers and over 40 crore consumers across 900 Indian cities creates a significant supply-demand flywheel that is expensive for new entrants to replicate from scratch. The defensibility is strongest in Tier 2 and Tier 3 cities where digital health infrastructure is sparse and Practo's network effects are hardest to displace. However, the same scale creates a vulnerability: any major hospital chain or pharmacy network (e.g., Apollo, PharmEasy) that builds a competing integrated platform can simultaneously attack Practo's provider and consumer sides, making vertical integration by incumbents the primary competitive threat rather than pure-play startups.

What does Practo's Ray Connect virtual assistant pricing — starting at ₹999/month — reveal about its strategy for monetizing smaller clinics?

Ray Connect's entry price of ₹999 per month for 1,000 credits is deliberately low-friction, designed to onboard smaller, price-sensitive clinics onto Practo's practice management stack where switching costs then accumulate over time. This land-and-expand model — hardware (Practo Tab at ₹17,000 one-time) plus tiered SaaS subscriptions — mirrors playbooks used by practice management platforms globally to convert clinics from paper-based workflows into sticky digital dependencies. For competitive analysts, this means Practo's B2B revenue stream from provider software is structurally stickier than its B2C consultation marketplace, and is likely the more defensible earnings base as it approaches IPO.

Powered by ForesightIQ · Competitive intelligence from digital exhaust